Logotype for SKAN Group AG

SKAN Group (SKAN) H2 2025 earnings summary

Event summary combining transcript, slides, and related documents.

Logotype for SKAN Group AG

H2 2025 earnings summary

24 Mar, 2026

Executive summary

  • Order intake rose 3.1% to CHF 370.6 million, with strong demand in Europe and a cautious U.S. market; order backlog increased 8.7% to CHF 346.1 million, supporting future visibility.

  • Net sales declined 7.7% to CHF 333.3 million due to above-average project postponements, mainly vaccine lines, shifting revenue into 2026 and 2027.

  • EBITDA dropped 32.3% to CHF 38.6 million (margin 11.6%), mainly from lower project business sales and higher operating expenses; profitability rebounded in H2 with a 19% margin.

  • Two strategic acquisitions (Metronik and ABC Transfer) expanded the high-margin Services and Consumables segment and broadened the offering.

  • Net profit reached CHF 17.6 million; a dividend of CHF 0.22 per share (30% payout ratio) is proposed.

Financial highlights

  • Order intake: CHF 370.6 million (+3.1% year-over-year); order backlog: CHF 346.1 million (+8.7%); book-to-bill ratio: 1.1x.

  • Net sales: CHF 333.3 million (-7.7% year-over-year; -6.4% at constant currency).

  • EBITDA: CHF 38.6 million (margin 11.6%), with H2 margin at 19%.

  • Operating cash flow: CHF 64.1 million, supported by advance payments and disciplined working capital.

  • ROCE: 10.3%, down due to higher capital employed and lower EBIT.

  • Net debt: CHF 37.4 million; net debt/EBITDA ratio of 0.97x; equity ratio: 26.5%, mainly due to acquisition-related goodwill.

  • Investments totaled CHF 45.9 million, mainly for Pre-Approved Services development.

Outlook and guidance

  • 2026 sales growth expected in the upper teens percentage range; midterm outlook unchanged with mid to upper teens sales growth and gradual EBITDA margin increase to upper teens.

  • EBITDA margin forecasted at 13%-15% for 2026.

  • Management expects a softer H1 2026 due to project timing, with stronger H2 performance anticipated.

  • Guidance assumes no major tariff escalations, limited impact from geopolitical conflicts, and no significant currency effects.

  • Services and Consumables, including Pre-Approved Services, are key growth and margin drivers.

  • Launch of Pre-Approved Services planned for H2 2026, aiming to shorten customers’ time-to-market.

Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.
All investor relations material. One API.
Learn more